Imax Corporation Reports Q4 And Full-Year 2023 Results

Tue, Feb 27, 2024
  • Global entertainment technology platform delivers over 25% YoY growth in FY23 across Revenue, Net Income, Adjusted EBITDA(1)and Adjusted EPS(1)(2)
  • Full-Year GAAP EPS of $0.46, up from a loss of ($0.40) in FY22; Full-Year Adjusted EPS of $0.94, up from $0.06in FY22
  • Net Income of $25 millionin FY23 increased from a loss of $(23) millionin 2022 while Adjusted EBITDA(2)increases to $128 millionin FY23, up 52% from $84 millionin FY22
  • System sales activity increases 174% YoY to 129 signings worldwide in FY23
  • Company delivers on high end of guidance with 128 system installations in FY23, up from 92 in FY22
  • IMAX achieves global box office of approximately $1.1 billion, approaching previous record
  • Full-Year cash from operations more than triples to $59 millionin FY23, up from $17 millionFY22

NEW YORK, Feb. 27, 2024/PRNewswire/ -- IMAX Corporation (NYSE: IMAX) today reported financial results for the Fourth Quarter and Full-Year 2023, highlighted by strong top and bottom-line growth for the full-year.

"IMAX delivered excellent results in 2023 — we grew Net Income by $48 million, Adjusted EPS by 88 cents, Adjusted EBITDA by 52%, and system installations by nearly 40%  — on the strength of demand for our technology, our unique premium model, and a clear preference among consumers worldwide for awe-inspiring IMAX experiences," said Rich Gelfond, CEO of IMAX.

"As the entertainment landscape transforms, it is clear that IMAX is among its premier, in-demand destinations. We drove significant expansion and diversification of our global footprint, with a record 61 of our system installations coming from strategic Rest of World markets such as Japan, South Koreaand Europe. Even as we deliver an outsized share of the global box office, we estimate the current IMAX network is only at 47% penetration — with the opportunity to open nearly 2,000 additional locations worldwide."

"Our strong network growth is a direct result of our global content strategy, which has yielded the biggest and most diverse portfolio of IMAX Experiences ever. 2023 saw IMAX deliver a record at the North American box office, highest grossing year ever for local language films and overall box office approaching our best year ever. We are strategically managing our content portfolio to drive greater share of Hollywoodreleases, grow local language, accelerate our pipeline of IMAX Documentaries, and push further into emerging verticals including music and gaming, live experiences and recurring programming."

"Through our global technology platform, IMAX powers awe-inspiring experiences for audiences around the world — capitalizing on the limitlessness of human imagination and need for shared experiences. We look forward to further capturing this opportunity, growing our network and content portfolio, to deliver results for our shareholders."

_______________

(1)

Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts.

  

(2)

Attributable to common shareholders.

 

Fourth Quarter and December Full-Year Financial Highlights

 
  

Three Months Ended

  

Year Ended

  

December 31,

  

December 31,

In millions of U.S.Dollars, except per share data

 

2023

  

2022

  

YoY %
Change

  

2023

  

2022

  

YoY %
Change

                  

Total Revenue

 

$

86.0

  

$

98.0

  

(12 %)

  

$

374.8

  

$

300.8

  

25 %

                  

Gross Margin

 

$

43.7

  

$

48.8

  

(11 %)

  

$

214.3

  

$

156.4

  

37 %

Gross Margin (%)

  

51

%

  

50

%

     

57

%

  

52

%

  
                  

Adjusted EBITDA - attributable to common shareholders(1)(3)

 

$

23.0

  

$

27.8

  

(17 %)

  

$

128.2

  

$

84.5

  

52 %

Adjusted EBITDA Margin (%) - attributable to common shareholders(1)(3)

  

28

%

  

31

%

 

(8 %)

   

37

%

  

30

%

 

22 %

                  

Total Adjusted EBITDA(1)(3)(4)

 

$

25.2

  

$

31.5

  

(20 %)

  

$

144.0

  

$

95.7

  

51 %

Total Adjusted EBITDA Margin (%)(1)(3)(4)

  

29

%

  

32

%

 

(9 %)

   

38

%

  

32

%

 

21 %

                  

Net Income (Loss)(2)

 

$

2.5

  

$

2.6

  

(3 %)

  

$

25.3

  

$

(22.8)

  

N/A

Net Income (Loss) per share(2)- basic and diluted

 

$

0.05

  

$

0.05

   

—

  

$

0.46

  

$

(0.40)

  

N/A

                  

Adjusted Net Income(1)(2)

 

$

9.3

  

$

10.6

  

(12 %)

  

$

52.1

  

$

3.2

  

N/A

Adjusted Earnings Per Share(1)(2)

 

$

0.17

  

$

0.19

  

(11 %)

  

$

0.94

  

$

0.06

  

N/A

                  

Weighted average shares outstanding (in millions)(5):

                 

Basic

  

54.0

   

54.8

  

(2 %)

   

54.3

   

56.7

  

(4 %)

Diluted

  

55.0

   

55.7

  

(1 %)

   

55.1

   

57.4

  

(4 %)

                       

_______________

(1)

Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts.

  

(2)

Attributable to common shareholders.

  

(3)

Per Credit Facility.

  

(4)

Total Adjusted EBITDA is equivalent to Total Adjusted EBITDA Attributable to Non-controlling Interests and Common Shareholders.

  

(5)

Reflects weighted average shares outstanding used in Adjusted Earnings Per Share calculation.

 

Fourth Quarter and Full Year Segment Results(1)

 
  

Content Solutions

  

Technology Products and Services

 
                    
  

Revenue

  

Gross Margin

  

Gross
Margin %

  

Revenue

  

Gross Margin

  

Gross
Margin %

 

4Q23

 

$

19.1

  

$

9.7

   

51

%

 

$

62.5

   

$

29.9

   

48

%

4Q22

  

29.3

   

12.1

   

41

%

  

66.1

    

35.2

   

53

%

% change

  

(35)

%

  

(20)

%

     

(5)

%

   

(15)

%

   
                    

FY23

 

$

126.7

  

$

74.1

   

58

%

 

$

234.3

   

$

129.9

   

55

%

FY22

  

101.8

   

51.2

   

50

%

  

192.4

    

101.1

   

53

%

% change

  

24

%

  

45

%

     

22

%

   

28

%

   

_______________

(1)

Please refer to the Company's Form 10-K for the year ended December 31, 2023for additional segment information.

Content Solutions Segment

  • Content Solutions revenue of $126.7 millionincreased 24% year-over-year for the full year 2023 while Q4 revenue of $19.1 milliondecreased 35% year-over-year. Gross box office from IMAX locations for full year 2023 of approximately $1.1 billionwas up 25% while Q4 2023 of $170 millionwas down 32% year-over-year. IMAX set numerous records for box office during 2023 including:
    • Highest full year local language box office of $227 million
    • Highest full year domestic box office of $393 million
    • Highest Q3 box office of $347 million
  • Gross margin for Content Solutions of $74.1 millionfor the full year 2023 increased 45% year-over-year while Q4 gross margin of $9.7 milliondecreased 20% year-over-year. The Company saw significant margin expansion for the full year 2023 (up 800 basis points) and Q4 2023 (up 1000 basis points) driven by the operating leverage in our business along with our disciplined cost management.

Technology Products and Services Segment

  • Technology Products and Services revenues and gross margin for full year 2023 increased 22% year-over-year to $234.3 millionand 28% year-over-year to $129.9 million, respectively. Q4 revenue and gross margin decreased 5% year-over-year to $62.5 millionand 15% year-over-year to $29.9 million, respectively.
  • For the full year 2023 the Company installed 128 systems compared to 92 systems in full year 2022. Of those, 75 systems were under sales and hybrid JRSA arrangements, compared to 46 systems in the prior year.
  • During the fourth quarter the Company installed 69 systems compared to 52 systems in the fourth quarter of 2022. Of those, 38 systems were under sales and hybrid JRSA arrangements, compared to 24 systems in the prior year.
  • Commercial network growth accelerated with the number of IMAX locations increasing 4% year-over-year to 1,693. The Company ended 2023 with a backlog of 450 IMAX systems.

Operating Cash Flow and Liquidity

Net cash provided by operating activities for full year 2023 was $58.6 millioncompared to $17.3 millionin the prior period with the increase reflecting the higher profits year-over-year and improvements in working capital.

As of December 31, 2023, the Company's available liquidity was $407 million. The Company's liquidity includes cash and cash equivalents of $76 million, $276 millionin available borrowing capacity under the Credit Facility, and $55 millionin available borrowing capacity under IMAX China's revolving facilities. Total debt, excluding deferred financing costs, was $257 millionas of December 31, 2023.

In 2021, the Company issued $230.0 millionof 0.500% Convertible Senior Notes due 2026 ("Convertible Notes"). In connection with the pricing of the Convertible Notes, the Company entered into privately negotiated capped call transactions with an initial cap price of $37.2750per share of the Company's common shares. 

Share Count and Capital Return

The weighted average basic and diluted shares outstanding used in the calculation of adjusted EPS for the full year of 2023 were 54.3 million and 55.1 million, respectively, compared to 56.7 million and 57.4 million, respectively for the full year 2022, a decrease year-over-year of 4% for both basic and diluted shares outstanding.

For the full year 2023, the Company repurchased 1.6 million common shares at an average price of $16.45per share, for a total of $26.4 million, excluding commission, with $24.2 millionof repurchases coming in the fourth quarter of 2023. Subsequent to year-end, the Company repurchased 1.2 million common shares at an average price of $13.99per share, for a total of $16.2 million, excluding commission, year-to-date through February 26, 2024.

On June 14, 2023, the Company announced a 3-year extension to its share-repurchase program through June 30, 2026. The current share-repurchase program authorizes the Company to repurchase up to $400.0 millionof its common shares, of which approximately $151.0 millionremains available.

2024 Guidance

The Company expects the following for the full year 2024:

  • IMAX Gross Box Office: Similar to 2023
  • System Installations: 120 to 150 Systems
  • Total Consolidated Adjusted EBITDA Margin: High 30's percent

Supplemental Materials

For more information about the Company's results, please refer to the IMAX Investor Relations website located at investors.imax.com.

Investor Relations Website and Social Media

On a monthly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at investors.imax.com. The Company expects to provide such updates within five business days of month-end, although the Company may change this timing without notice.

The Company may post additional information on the Company's corporate and Investor Relations website which may be material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website in addition to the Company's press releases, SECfilings and public conference calls and webcasts, for additional information about the Company.

Conference Call

The Company will host a conference call today at 4:30 PM ETto discuss its full year and fourth quarter 2023 financial results. This call is being webcast and can be accessed at investors.imax.com. To access the call via telephone, interested parties please pre-register here: https://register.vevent.com/register/BI5eba9aa253da46dfb62bb6d573394a9d and you will be provided with a dial-in number and unique pin. To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time. A replay of the call will be available via webcast at investors.imax.com.

About IMAX Corporation 

IMAX, an innovator in entertainment technology, combines proprietary software, architecture, and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX systems to connect with audiences in extraordinary ways, making IMAX's network among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto, and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of December 31, 2023, there were 1,772 IMAX systems (1,693 commercial multiplexes, 12 commercial destinations, 67 institutional) operating in 90 countries and territories. Shares of IMAX China Holding, Inc., a subsidiary of IMAX Corporation, trade on the Hong Kong Stock Exchangeunder the stock code "1970".

IMAX®, IMAX®3D, Experience It In IMAX®, The IMAX Experience®, DMR®, Filmed For IMAX®, IMAX LIVETM, IMAX Enhanced® are trademarks and trade names of IMAX Corporationor its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. For more information, visit www.imax.com. You can also connect with IMAX on Instagram (www.instagram.com/company/imax), Facebook (www.facebook.com/imax), LinkedIn (www.linkedin.com/company/imax), X (www.twitter.com/imax), and YouTube (www.youtube.com/imaxmovies).

For additional information please contact:

Investors:

IMAX Corporation, New York

Jennifer Horsley

212-821-0154

[email protected] 

Media: 

IMAX Corporation, New York
Mark Jafar
212-821-0102
[email protected] 

Forward-Looking Statements

This earnings release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. These forward-looking statements include, but are not limited to, business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, future capital expenditures (including the amount and nature thereof), industry prospects and consumer behavior, plans and references to the future success of IMAX Corporationtogether with its consolidated subsidiaries (the "Company") and expectations regarding the Company's future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United Statesand Canada, as well as geopolitical conflicts; risks related to the Company's growth and operations in China; the performance of IMAX remastered films and other films released to the IMAX network; the signing of IMAX System agreements; conditions, changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates, including competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks relating to consolidation among commercial exhibitors and studios; risks related to brand extensions and new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security and data privacy; risks related to the Company's inability to protect the Company's intellectual property; risks related to climate change; risks related to weather conditions and natural disasters that may disrupt or harm the Company's business; risks related to the Company's indebtedness and compliance with its debt agreements; general economic, market or business conditions; risks related to political, economic and social instability; the failure to convert system backlog into revenue; changes in laws or regulations; any statements of belief and any statements of assumptions underlying any of the foregoing; other factors and risks outlined in the Company's periodic filings with the SEC; and other factors, many of which are beyond the control of the Company. Consequently, all of the forward-looking statements made in this earnings release are qualified by these cautionary statements, and actual results or anticipated developments by the Company may not be realized, and even if substantially realized, may not have the expected consequences to, or effects on, the Company. These factors, other risks and uncertainties and financial details are discussed in the Company's most recent Annual Report on Form 10-K. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Primary Reporting Groups

The Company's Chief Executive Officer ("CEO") is its Chief Operating Decision Maker ("CODM"), as such term is defined under U.S.GAAP. The CODM, along with other members of management, assesses segment performance based on segment revenues and gross margins. Selling, general and administrative expenses, research and development costs, the amortization of intangible assets, provision for (reversal of) current expected credit losses, certain write-downs, interest income, interest expense, and income tax (expense) benefit are not allocated to the Company's segments.

In the first quarter of 2023, the Company revised its internal segment reporting, including the information provided to the CODM to assess segment performance and allocate resources.

The Company has the following reportable segments:

(i)                 

Content Solutions, which principally includes the digital remastering of films and other content into IMAX formats for distribution to the IMAX network. To a lesser extent, the Content Solutions segment also earns revenue from the distribution of large-format documentary films and exclusive experiences ranging from live performances to interactive events with leading artists and creators, as well as film post-production services.

  

(ii)                 

Technology Products and Services, which includes results from the sale or lease of IMAX Systems, as well as from the maintenance of IMAX Systems. To a lesser extent, the Technology Product and Services segment also earns revenue from certain ancillary theater business activities, including after-market sales of IMAX System parts and 3D glasses.

Transactions between segments are valued at exchange value. Inter-segment profits are eliminated upon consolidation, as well as for the disclosures below.

 

IMAX Network and Backlog

 
  
  

Three Months
Ended December 31,

  

Year
Ended December 31,

 

System Signings(1):

 

2023

  

2022

  

2023

  

2022

 

Sales Arrangements

  

10

   

11

   

64

   

21

 

Hybrid JRSA

  

—

   

—

   

—

   

3

 

Traditional JRSA

  

25

   

1

   

65

   

23

 

   Total IMAX System signings

  

35

   

12

   

129

   

47

 
             
  

Three Months
Ended December 31,

  

Year
Ended December 31,

 

System Installations(2):

 

2023

  

2022

  

2023

  

2022

 

Sales Arrangements

  

35

   

21

   

70

   

38

 

Hybrid JRSA

  

3

   

3

   

5

   

8

 

Traditional JRSA

  

31

   

28

   

53

   

46

 

   Total IMAX System installations

  

69

   

52

   

128

   

92

 

 

  

Year
Ended December 31,

  

System Backlog:

 

2023

   

2022

  

Sales Arrangements

  

164

    

162

  

Hybrid JRSA

  

103

    

120

  

Traditional JRSA

  

183

    

168

  

Total System backlog

  

450

    

450

  
         
  

Year
Ended December 31,

  

System Network:

 

2023

   

2022

  

Commercial Multiplex Systems

        

Sales Arrangements

  

769

    

702

  

Hybrid JRSA

  

138

    

151

  

Traditional JRSA

  

786

    

780

  

Total Commercial Multiplex Systems

  

1,693

    

1,633

  

Commercial Destination Systems

  

12

    

12

  

Institutional Systems

  

67

    

71

  

Total System network

  

1,772

    

1,716

  

______________

(1)

System signings include new signings of 32 in Q4 2023, 9 in Q4 2022, 108 in the full year 2023 and 30 in the full year 2022.

  

(2)

System installations include new systems installations of 47 in Q4 2023, 21 in Q4 2022, 86 in the full year 2023 and 56 in the full year 2022.

 

IMAX CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands of U.S.dollars, except per share amounts)

 
   

Three Months Ended

       
   

December 31,

  

Year Ended

 
   

(Unaudited)

  

December 31,

 
   

2023

  

2022

  

2023

  

2022

 

Revenues

            

Technology sales

 

$

35,337

  

$

33,888

  

$

100,792

  

$

69,158

 

Image enhancement and maintenance services

  

35,508

   

44,094

   

189,752

   

161,379

 

Technology rentals

  

12,954

   

18,060

   

75,566

   

61,786

 

Finance income

  

2,219

   

2,004

   

8,729

   

8,482

 
    

86,018

   

98,046

   

374,839

   

300,805

 

Costs and expenses applicable to revenues

            

Technology sales

  

17,805

   

17,346

   

46,756

   

37,610

 

Image enhancement and maintenance services

  

18,586

   

25,575

   

88,056

   

81,834

 

Technology rentals

  

5,939

   

6,278

   

25,686

   

25,006

 
    

42,330

   

49,199

   

160,498

   

144,450

 

Gross margin

  

43,688

   

48,847

   

214,341

   

156,355

 

Selling, general and administrative expenses

  

35,070

   

37,862

   

144,406

   

138,043

 

Research and development

  

2,722

   

1,633

   

10,110

   

5,300

 

Amortization of intangible assets

  

1,250

   

1,417

   

4,578

   

4,829

 

Credit loss expense (reversal), net

  

170

   

398

   

1,759

   

8,547

 

Asset impairments

  

144

   

—

   

144

   

4,470

 

Restructuring and executive transition costs

  

1,593

   

—

   

2,946

   

—

 

Income (loss) from operations

  

2,739

   

7,537

   

50,398

   

(4,834)

 

Realized and unrealized investment gains (losses)

  

29

   

(29)

   

465

   

70

 

Retirement benefits non-service expense

  

(179)

   

(139)

   

(411)

   

(556)

 

Interest income

  

648

   

252

   

2,486

   

1,428

 

Interest expense

  

(1,776)

   

(1,523)

   

(6,821)

   

(5,877)

 

Income (loss) before taxes

  

1,461

   

6,098

   

46,117

   

(9,769)

 

Income tax recovery (expense)

  

1,850

   

(2,017)

   

(13,051)

   

(10,108)

 

Net income (loss)

  

3,311

   

4,081

   

33,066

   

(19,877)

 

Net income attributable to non-controlling interests

  

(771)

   

(1,468)

   

(7,731)

   

(2,923)

 

Net income (loss) attributable to common shareholders

 

$

2,540

  

$

2,613

  

$

25,335

  

$

(22,800)

 
              

Net income (loss) per share attributable to common shareholders

 
 

Basic

 

$

0.05

  

$

0.05

  

$

0.47

  

$

(0.40)

 
 

Diluted

 

$

0.05

  

$

0.05

  

$

0.46

  

$

(0.40)

 
              

Weighted average shares outstanding (in thousands):

 
 

Basic

  

53,973

   

54,816

   

54,310

   

56,674

 
 

Diluted

  

54,983

   

55,659

   

55,146

   

56,674

 

Additional Disclosure:

            

Depreciation and amortization

 

$

13,545

  

$

13,998

  

$

60,022

  

$

56,661

 

Amortization of deferred financing costs

 

$

493

  

$

712

  

$

2,235

  

$

3,177

 

 

IMAX CORPORATION

CONSOLIDATED BALANCE SHEETS

(In thousands of dollars, except share amounts)

 
  

As of December 31,

 
  

2023

  

2022

 

Assets

      

Cash and cash equivalents

 

$

76,200

  

$

97,401

 

Accounts receivable, net of allowance for credit losses

  

136,259

   

136,142

 

Financing receivables, net of allowance for credit losses

  

127,154

   

129,384

 

Variable consideration receivable, net of allowance for credit losses

  

64,338

   

44,024

 

Inventories

  

31,584

   

31,534

 

Prepaid expenses

  

12,345

   

12,343

 

Film assets, net of accumulated amortization

  

6,786

   

5,277

 

Property, plant and equipment, net of accumulated depreciation

  

243,299

   

252,896

 

Investment in equity securities

  

—

   

1,035

 

Other assets

  

20,879

   

15,665

 

Deferred income tax assets, net of valuation allowance

  

7,988

   

9,900

 

Goodwill

  

52,815

   

52,815

 

Other intangible assets, net of accumulated amortization

  

35,022

   

32,738

 

Total assets

 

$

814,669

  

$

821,154

 

Liabilities

      

Accounts payable

 

$

26,386

  

$

25,237

 

Accrued and other liabilities

  

111,013

   

117,286

 

Deferred revenue

  

67,105

   

70,940

 

Revolving credit facility borrowings, net of unamortized debt issuance costs

  

22,924

   

36,111

 

Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs

 

229,131

   

226,912

 

Deferred income tax liabilities

  

12,521

   

14,900

 

Total liabilities

  

469,080

   

491,386

 

Commitments, contingencies and guarantees

      

Non-controlling interests

  

658

   

722

 

Shareholders' equity

      

Capital stock common shares — no par value. Authorized — unlimited number.

      

53,260,276 issued and outstanding (December 31, 2022— 54,148,614 issued and outstanding)

  

389,048

   

376,715

 

Other equity

  

185,087

   

185,678

 

Statutory surplus reserve

  

3,932

   

3,932

 

Accumulated deficit

  

(292,845)

   

(293,124)

 

Accumulated other comprehensive loss

  

(12,081)

   

(9,846)

 

Total shareholders' equity attributable to common shareholders

  

273,141

   

263,355

 

Non-controlling interests

  

71,790

   

65,691

 

Total shareholders' equity

  

344,931

   

329,046

 

Total liabilities and shareholders' equity

 

$

814,669

  

$

821,154

 

 

IMAX CORPORATION 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands of dollars)

 
  

Years Ended December 31,

 
  

2023

  

2022

 

Operating Activities

        

Net income (loss)

 

$

 

33,066

  

$

 

(19,877)

 

Adjustments to reconcile net income (loss) to cash provided by operating activities:

        

Depreciation and amortization

   

60,022

    

56,661

 

Amortization of deferred financing costs

   

2,235

    

3,177

 

Credit loss expense, net

   

1,759

    

8,547

 

Write-downs, including asset impairments

   

1,884

    

7,176

 

Deferred income tax benefit

   

(1,447)

    

(2,073)

 

Share-based and other non-cash compensation

   

24,230

    

27,573

 

Unrealized foreign currency exchange (gain) loss

   

(212)

    

1,108

 

Realized and unrealized investment gain

   

(465)

    

(70)

 

Changes in assets and liabilities:

        

Accounts receivable

   

(1,907)

    

(29,003)

 

Inventories

   

(285)

    

(5,529)

 

Film assets

   

(20,394)

    

(19,598)

 

Deferred revenue

   

(3,882)

    

(11,572)

 

Changes in other operating assets and liabilities

   

(35,989)

    

801

 

Net cash provided by operating activities

   

58,615

    

17,321

 

Investing Activities

        

Purchase of property, plant and equipment

   

(6,491)

    

(8,424)

 

Investment in equipment for joint revenue sharing arrangements

   

(18,000)

    

(19,803)

 

Interest in film classified as a financial instrument

   

—

    

(4,731)

 

Acquisition of other intangible assets

   

(8,344)

    

(4,394)

 

Proceeds from sale of equity securities

   

1,045

    

—

 

Acquisition of SSIMWAVE Inc., net of cash and cash equivalents acquired

   

—

    

(15,939)

 

Net cash used in investing activities

   

(31,790)

    

(53,291)

 

Financing Activities

        

Proceeds from revolving credit facility borrowings

   

39,717

    

37,871

 

Repayments of revolving credit facility borrowings

   

(53,248)

    

(3,600)

 

Proceeds from other borrowings

   

322

    

—

 

Repayment of other borrowings

   

(53)

    

—

 

Credit facility amendment fees paid

   

(46)

    

(2,279)

 

Repurchase of common shares, IMAX Corporation

   

(26,823)

    

(80,124)

 

Repurchase of common shares, IMAX China

   

(15)

    

(3,043)

 

Taxes withheld and paid on employee stock awards vested

   

(6,466)

    

(3,687)

 

Principal payment under finance lease obligations

   

(480)

    

(948)

 

Dividends paid to non-controlling interests

   

(1,438)

    

(2,704)

 

Net cash used in financing activities

   

(48,530)

    

(58,514)

 

Effects of exchange rate changes on cash

   

504

    

2,174

 

Decrease in cash and cash equivalents during year

   

(21,201)

    

(92,310)

 

Cash and cash equivalents, beginning of year

   

97,401

    

189,711

 

Cash and cash equivalents, end of year

 

$

 

76,200

  

$

 

97,401

 

 

Segment Revenue and Gross Margin

 

(In thousands of dollars)

 

Three Months Ended

  

Years Ended

 
  

December 31,

  

December 31,

 
  

2023

  

2022

  

2023

  

2022

 

Revenue

            

Content Solutions

  

19,093

   

29,320

   

126,698

   

101,820

 

Technology Products and Services

  

62,490

   

66,107

   

234,303

   

192,368

 

Sub-total for reportable segments

  

81,583

   

95,427

   

361,001

   

294,188

 

All Other(1)

  

4,435

   

2,619

   

13,838

   

6,617

 

Total

 

$

86,018

  

$

98,046

  

$

374,839

  

$

300,805

 
             

Gross Margin

            

Content Solutions

  

9,709

   

12,122

   

74,106

   

51,240

 

Technology Products and Services

  

29,880

   

35,179

   

129,946

   

101,055

 

Sub-total for reportable segments

  

39,589

   

47,301

   

204,052

   

152,295

 

All Other(1)

  

4,099

   

1,546

   

10,289

   

4,060

 

Total

 

$

43,688

  

$

48,847

  

$

214,341

  

$

156,355

 

______________

(1)     All Other includes the results from Streaming and Consumer Technology and other ancillary activities.

IMAX CORPORATION
NON-GAAP FINANCIAL MEASURES
(in thousands of U.S.dollars)

In this release, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per basic and diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin as supplemental measures of the Company's performance, which are not recognized under U.S.GAAP. Adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per basic and diluted share exclude, where applicable: (i) share-based compensation; (ii) COVID-19 government relief benefits, net; (iii) realized and unrealized investment gains or losses; (iv) transaction-related expenses; and (v) restructuring and executive transition costs, as well as the related tax impact of these adjustments.

The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company's financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual items included in net income (loss) attributable to common shareholders. Although share-based compensation is an important aspect of the Company's employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures.

A reconciliation from net income (loss) attributable to common shareholders and the associated per share amounts to adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below. Net income (loss) attributable to common shareholders and the associated per share amounts are the most directly comparable GAAP measures because they reflect the earnings relevant to the Company's shareholders, rather than the earnings attributable to non-controlling interests.

In addition to the non-GAAP financial measures discussed above, management also uses "EBITDA," as such term is defined in the Company's Credit Agreement, and which is referred to herein as "Adjusted EBITDA per Credit Facility." As allowed by the Credit Agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Adjusted EBITDA per Credit Facility measure is presented to allow a more comprehensive analysis of the Company's operating performance and to provide additional information with respect to the Company's compliance against its Credit Agreement requirements when applicable. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry to evaluate, assess and benchmark the Company's results.

EBITDA is defined as net income or loss excluding (i) income tax expense or benefit; (ii) interest expense, net of interest income; (iii) depreciation and amortization, including film asset amortization; and (iv) amortization of deferred financing costs. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) share-based and other non-cash compensation; (ii) realized and unrealized investment gains or losses; (iii) transaction-related expenses; (iv) restructuring and executive transition costs; and (v) write-downs, net of recoveries, including asset impairments and credit loss expense.

A reconciliation of net income (loss) attributable to common shareholders, which is the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA per Credit Facility is presented in the table below. Net income (loss) attributable to common shareholders is the most directly comparable GAAP measure because it reflects the earnings relevant to the Company's shareholders, rather than the earnings attributable to non-controlling interests.

In this release, the Company also presents free cash flow, which is not recognized under U.S.GAAP, as a supplemental measure of the Company's liquidity. The Company definition of free cash flow deducts only normal recurring capital expenditures, including the Company's investment in joint revenue sharing arrangements, the purchase of property, plant and equipment and the acquisition of other intangible assets (from the Consolidated Statements of Cash Flows), from net cash provided by or used in operating activities. Management believes that free cash flow is a supplemental measure of the cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented below.

These non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Additionally, the non-GAAP financial measures used by the Company should not be considered as a substitute for, or superior to, the comparable GAAP amounts.

 

Adjusted EBITDA per Credit Facility

 
  

For the Three Months Ended December 31, 2023 (1)

  

For the Three Months Ended December 31, 2022 (1)

 
  

Attributable to
Non-controlling

  

Less:

     

Attributable to
Non-controlling

  

Less:

    
  

Interests and

  

Attributable to

  

Attributable to

  

Interests and

  

Attributable to

  

Attributable to

 
  

Common

  

Non-controlling

  

Common

  

Common

  

Non-controlling

  

Common

 
  

Shareholders

  

Interests

  

Shareholders

  

Shareholders

  

Interests

  

Shareholders

 

(In thousands of U.S.Dollars)

                        

Reported net income

 

$

 

3,311

  

$

 

771

  

$

 

2,540

  

$

 

4,081

  

$

 

1,468

  

$

 

2,613

 

Add (subtract):

                        

Income tax expense

   

(1,850)

    

(147)

    

(1,703)

    

2,016

    

786

    

1,230

 

Interest expense, net of interest income

   

636

    

(137)

    

773

    

559

    

(15)

    

574

 

Depreciation and amortization, including film asset
amortization

   

13,545

    

1,161

    

12,384

    

13,998

    

1,109

    

12,889

 

Amortization of deferred financing costs(2)

   

493

    

—

    

493

    

712

    

—

    

712

 

EBITDA

 

$

 

16,135

  

$

 

1,648

  

$

 

14,487

  

$

 

21,366

  

$

 

3,348

  

$

 

18,018

 

Stock and other non-cash compensation

   

6,400

    

144

    

6,256

    

8,063

    

205

    

7,858

 

Unrealized investment (gains) losses

   

(29)

    

—

    

(29)

    

29

    

—

    

29

 

Transaction-related expenses(3)

   

327

    

208

    

119

    

166

    

—

    

166

 

Write-downs, including asset impairments and
credit loss expense

   

812

    

(37)

    

849

    

1,867

    

162

    

1,705

 

Restructuring and executive transition costs(4)

   

1,593

    

258

    

1,335

    

—

    

—

    

—

 

Adjusted EBITDA per Credit Facility

 

$

 

25,238

  

$

 

2,221

  

$

 

23,017

  

$

 

31,491

  

$

 

3,715

  

$

 

27,776

 

Revenues attributable to common shareholders(5)

   

86,018

    

4,687

    

81,331

    

98,046

    

7,273

    

90,773

 

Adjusted EBITDA margin attributable to common
shareholders

   

29.3

%

   

47.4

%

   

28.3

%

   

32.1

%

   

51.1

%

   

30.6

%

                         
  

For the Twelve Months Ended December 31, 2023 (1)

  

For the Twelve Months Ended December 31, 2022 (1)

 
  

Attributable to
Non-controlling

  

Less:

     

Attributable to
Non-controlling

  

Less:

    
  

Interests and

  

Attributable to

  

Attributable to

  

Interests and

  

Attributable to

  

Attributable to

 
  

Common

  

Non-controlling

  

Common

  

Common

  

Non-controlling

  

Common

 
  

Shareholders

  

Interests

  

Shareholders

  

Shareholders

  

Interests

  

Shareholders

 

(In thousands of U.S.Dollars)

                        

Reported net income (loss)

 

$

 

33,066

  

$

 

7,731

  

$

 

25,335

  

$

 

(19,877)

  

$

 

2,923

  

$

 

(22,800)

 

Add (subtract):

                        

Income tax expense

   

13,051

    

1,725

    

11,326

    

10,108

    

1,256

    

8,852

 

Interest expense, net of interest income

   

2,101

    

(408)

    

2,509

    

1,272

    

(251)

    

1,523

 

Depreciation and amortization, including film asset
   amortization

   

60,022

    

5,312

    

54,710

    

56,661

    

4,820

    

51,841

 

Amortization of deferred financing costs(2)

   

2,235

    

—

    

2,235

    

3,177

    

—

    

3,177

 

EBITDA

 

$

 

110,475

  

$

 

14,360

  

$

 

96,115

  

$

 

51,341

  

$

 

8,748

  

$

 

42,593

 

Stock and other non-cash compensation

   

24,230

    

774

    

23,456

    

27,573

    

760

    

26,813

 

Unrealized investment gains

   

(465)

    

(93)

    

(372)

    

(70)

    

—

    

(70)

 

Transaction-related expenses(3)

   

3,569

    

208

    

3,361

    

1,122

    

—

    

1,122

 

Write-downs, including asset impairments and
credit loss expense

   

3,273

    

362

    

2,911

    

15,723

    

1,723

    

14,000

 

Restructuring and executive transition costs(4)

   

2,946

    

258

    

2,688

    

—

    

—

    

—

 

Adjusted EBITDA per Credit Facility

 

$

 

144,028

  

$

 

15,869

  

$

 

128,159

  

$

 

95,689

  

$

 

11,231

  

$

 

84,458

 

Revenues attributable to common shareholders(5)

   

374,839

    

25,674

    

349,165

    

300,805

    

20,883

    

279,922

 

Adjusted EBITDA margin attributable to common
shareholders

   

38.4

%

   

61.8

%

   

36.7

%

   

31.8

%

   

53.8

%

   

30.2

%

______________

(1)

The Senior Secured Net Leverage Ratio is calculated using Adjusted EBITDA per Credit Facility determined on a trailing twelve-month basis.

  

(2)

The amortization of deferred financing costs is recorded within Interest Expense in the Condensed Consolidated Statement of Operations.

  

(3)

Reflects costs incurred resulting from the Company's proposal to acquire the outstanding 96.3 million shares in IMAX China.

  

(4)

Reflects costs in connection with the departure of the President, IMAX Entertainmentand Executive Vice President of the Company and other employees to capture efficiencies and centralize certain operational roles.

  

(5)

 

(In thousands of U.S.Dollars)

 

Three months ended
December 31, 2023

  

Three months ended
December 31, 2022

  

Year ended
December 31, 2023

  

Year ended
December 31, 2022

 

Total revenues

     

$

 

86,018

      

$

 

98,046

      

$

 

374,839

     

$

 

300,805

 

Greater Chinarevenues

 

$

 

16,521

      

$

 

25,728

      

$

 

90,496

      

$

 

73,330

    

Non-controlling interest ownership
percentage(6)

   

28.37

%

       

28.27

%

       

28.37

%

       

28.48

%

   

Deduction for non-controlling interest
share of revenues

       

(4,687)

        

(7,273)

        

(25,674)

       

(20,883)

 

Revenues attributable to common
shareholders

     

$

 

81,331

      

$

 

90,773

      

$

 

349,165

     

$

 

279,922

 
  

(6)

Weighted average ownership percentage for change in non-controlling interest share

 

Adjusted Net Income Attributable to Common Shareholders and Adjusted Net Income Per Share

 
  

Three Months Ended

  

Three Months Ended

 
  

December 31, 2023

  

December 31, 2022

 

(In thousands of U.S.dollars, except per share amounts)

 

Net Income

  

Per Diluted
Share

  

Net Income

  

Per Diluted
Share

 

Net income attributable to common shareholders

 

$

2,540

  

$

0.05

  

$

2,613

  

$

0.05

 

Adjustments(1):

            

Share-based compensation

  

6,074

   

0.11

   

7,730

   

0.14

 

Unrealized investment gains

  

(32)

   

—

   

29

   

—

 

Transaction-related expenses(2)

  

119

   

—

   

166

   

—

 

Restructuring and executive transition costs(3)

  

1,335

   

0.02

   

—

   

—

 

Tax impact on items listed above

  

(747)

   

(0.01)

   

17

   

—

 

Adjusted net income(1)

 

$

9,289

  

$

0.17

  

$

10,555

  

$

0.19

 
             

Weighted average basic shares outstanding

     

53,973

      

54,816

 

Weighted average diluted shares outstanding

     

54,983

      

55,659

 
       
  

Year Ended

  

Year Ended

 
  

December 31, 2023

  

December 31, 2022

 

(In thousands of U.S.dollars, except per share amounts)

 

Net Income

  

Per Diluted
Share

  

Net (Loss)
Income

  

Per Diluted
Share

 

Net income (loss) attributable to common shareholders

 

$

25,335

  

$

0.46

  

$

(22,800)

  

$

(0.40)

 

Adjustments(1):

            

Share-based compensation

  

23,184

   

0.42

   

26,382

   

0.46

 

COVID-19 government relief benefits, net

  

—

   

—

   

(373)

   

(0.01)

 

Unrealized investment gains

  

(558)

   

(0.01)

   

(70)

   

—

 

Transaction-related expenses(2)

  

3,361

   

0.06

   

1,122

   

0.02

 

Restructuring and executive transition costs(3)

  

2,688

   

0.05

   

—

   

—

 

Tax impact on items listed above

  

(1,931)

   

(0.04)

   

(1,054)

   

(0.02)

 

Adjusted net income(1)

 

$

52,079

  

$

0.94

  

$

3,207

  

$

0.06

 
             

 Weighted average shares outstanding - basic

     

54,310

      

56,674

 

 Weighted average shares outstanding - diluted

     

55,146

      

57,371

 

 _______________

(1)

Reflects amounts attributable to common shareholders.

  

(2)

Reflects costs in connection with the Company's proposal to acquire the outstanding 96.3 million shares in IMAX China in 2023 and costs incurred associated with the acquisition of SSIMWAVE in 2022.

  

(3)

Reflects costs in connection with the departure of the President, IMAX Entertainmentand Executive Vice President of the Company and other employees to capture efficiencies and centralize certain operational roles.

 

Free Cash Flow

 
  

Year Ended

  

Year Ended

 

(In thousands of U.S.Dollars)

 

December 31, 2023

  

December 31, 2022

 

Net cash provided by operating activities

 

$

 

58,615

  

$

 

17,321

 

Purchase of property, plant and equipment

   

(6,491)

    

(8,424)

 

Acquisition of other intangible assets

   

(8,344)

    

(4,394)

 

Free cash flow before growth CAPEX

   

43,780

    

4,503

 

Investment in equipment for joint revenue sharing arrangements

   

(18,000)

    

(19,803)

 

Free cash flow

 

$

 

25,780

  

$

 

(15,300)

 

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/imax-corporation-reports-q4-and-full-year-2023-results-302073255.html

SOURCE IMAX Corporation